First Time Loading...
J

Jeisys Medical Inc
KOSDAQ:287410

Watchlist Manager
Jeisys Medical Inc
KOSDAQ:287410
Watchlist
Price: 9 630 KRW 3.55% Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Jeisys Medical Inc

Wall Street analysts forecast Jeisys Medical Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jeisys Medical Inc is 13 698.6 KRW with a low forecast of 10 403 KRW and a high forecast of 17 850 KRW.

Lowest Forecast
Wall Street Target
10 403 KRW
8% Upside
Average Forecast
Wall Street Target
13 698.6 KRW
42% Upside
Highest Forecast
Wall Street Target
17 850 KRW
85% Upside
Lowest
Price Target
10 403 KRW
8% Upside
Average
Price Target
13 698.6 KRW
42% Upside
Highest
Price Target
17 850 KRW
85% Upside
Jeisys Medical Inc Competitors:
Price Targets
CODX
Co-Diagnostics Inc
118% Upside
METN
Metall Zug AG
69% Upside
4543
Terumo Corp
13% Upside
GN
GN Store Nord A/S
14% Upside
CODX
Co-Diagnostics Inc
118% Upside
METN
Metall Zug AG
69% Upside
4543
Terumo Corp
13% Upside
GN
GN Store Nord A/S
14% Upside
V
VREX
Varex Imaging Corp
71% Upside
6699
Angelalign Technology Inc
6% Upside
SRDX
Surmodics Inc
81% Upside
GMED
Globus Medical Inc
24% Upside

Revenue
Forecast

Revenue Estimate
Jeisys Medical Inc

The compound annual growth rate of Jeisys Medical Inc's revenue for the next 4 years is 22%.

N/A
Past Growth
22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Jeisys Medical Inc

The compound annual growth rate of Jeisys Medical Inc's operating income for the next 4 years is 34%.

N/A
Past Growth
34%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Jeisys Medical Inc

The compound annual growth rate of Jeisys Medical Inc's net income for the next 4 years is 43%.

N/A
Past Growth
43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jeisys Medical Inc's stock price target?
Price Target
13 698.6 KRW

According to Wall Street analysts, the average 1-year price target for Jeisys Medical Inc is 13 698.6 KRW with a low forecast of 10 403 KRW and a high forecast of 17 850 KRW.

What is Jeisys Medical Inc's Revenue forecast?
Projected CAGR
22%

The compound annual growth rate of Jeisys Medical Inc's revenue for the next 4 years is 22%.

What is Jeisys Medical Inc's Operating Income forecast?
Projected CAGR
34%

The compound annual growth rate of Jeisys Medical Inc's operating income for the next 4 years is 34%.

What is Jeisys Medical Inc's Net Income forecast?
Projected CAGR
43%

The compound annual growth rate of Jeisys Medical Inc's net income for the next 4 years is 43%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.